Title

Risk Adapted Therapy Utilizing Upfront Brentuximab Vedotin (Bv) and Rituximab (R) With Reduced Toxicity Chemotherapy in the Treatment of Children, Adolescents and Young Adults (CAYA) With Newly Diagnosed Hodgkin Lymphoma (HL)

Document Type

Abstract

Publication Date

June 2017

Department

Pediatrics

Second Department

Epidemiology and Community Health

Share

COinS